Addiction

John Oliver

Health

From rural Kentucky to HBO: The story of the Sackler deposition hits pop culture big-time

By Andrew Joseph

Harm reduction

First Opinion

Sobriety is just one pathway to recovery. Harm reduction is another

By Susan E. Collins

advertisement

TUFTS - Sackler

Special Report

‘We owe much to the Sackler family’: How gifts to a top medical school advanced the interests of Purdue Pharma

By Andrew Joseph

advertisement

Drug Encampment In Kensington Area

First Opinion

Overdose prevention sites can help cities like Philadelphia save lives

By Thomas Farley

Packets of buprenorphine

First Opinion

Do business concerns keep doctors from treating opioid addiction?

By David A. Patterson Silver Wolf

Painkillers

Pharma

N.Y. attorney general targets Sackler family with allegations tied to Purdue Pharma

By Associated Press

Donald Stern

Health

Tufts taps former U.S. attorney to investigate ties to Sackler family, Purdue Pharma

By Andrew Joseph

advertisement

Rep. Elijah Cummings

Politics

House Democrats request Purdue opioid documents, focusing on the role of the Sacklers

By Andrew Joseph

advertisement

UnitedHealth

First Opinion

Landmark ruling sets precedent for parity coverage of mental health and addiction treatment

By Patrick J. Kennedy and Jim Ramstad

Suboxone

First Opinion

Deregulating buprenophine prescribing for opioid use disorder will save lives

By Kevin Fiscella and Sarah E. Wakeman

Suicide Mental Health

First Opinion

Deaths of despair can be prevented with a comprehensive strategy

By Benjamin F. Miller and John Auerbach

Purdue Pharma headquarters

Business

If Purdue Pharma declares bankruptcy, what would it mean for lawsuits against the opioid manufacturer?

By Andrew Joseph

The Readout LOUD

Listen: A big scoop on opioid marketing

By Rebecca Robbins, Adam Feuerstein, and Andrew Joseph

The Sackler Wing

Business

Intensely private, deeply invested: Richard Sackler’s role in promoting OxyContin emerges in court documents

By Andrew Joseph

Richard Sackler

Special Report

Purdue’s Sackler embraced plan to conceal OxyContin’s strength from doctors, sealed deposition shows

By David Armstrong — ProPublica

Purdue Pharma courthouse protest

Health

Massachusetts releases its full lawsuit against Purdue, the maker of OxyContin

By Andrew Joseph

STAT Purdue illustration

Pharma

Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction

By David Armstrong — ProPublica

Pharma Court Protest - Boston

Health

Judge orders full release of redacted lawsuit against Purdue Pharma, maker of OxyContin

By Andrew Joseph

Purdue Pharma headquarters

Health

Judge will rule next week on media request to disclose allegations against Purdue Pharma

By Andrew Joseph

Purdue Pharmaceuticals

Health

Tufts to review ties to Purdue Pharma after ‘deeply troubling’ disclosures

By Andrew Joseph

MGH

Health

Purdue cemented ties with universities and hospitals to expand opioid sales, documents contend

By Andrew Joseph

Healey

Health

‘A blizzard of prescriptions’: Documents reveal new details about Purdue’s marketing of OxyContin

By Andrew Joseph

Purdue Pharmaceuticals

Health

Purdue appeals order to unseal OxyContin records to Kentucky Supreme Court

By Andrew Joseph

Michael Babich

Pharma

Former Insys CEO pleads guilty to fentanyl bribery scheme

By Maria Cramer — Boston Globe

Inmates Hepatitis C

First Opinion

‘Nominal pricing’ can help prisons and jails treat hepatitis C without breaking the bank

By Anne C. Spaulding and Jagpreet Chhatwal

Church of Safe Injection

Health

Welcome to the Church of Safe Injection: Clean syringes are salvation and membership may help skirt the law

Purdue Pharmaceuticals

Health

Purdue’s secret OxyContin papers should be released, appeals court rules

By David Armstrong and Andrew Joseph

Health Insurance Claim Form

First Opinion

Patients need policymakers’ help to enforce mental health parity laws

By Patrice A. Harris and Ellen Weber

Hoarding Opioids

First Opinion

Overzealous use of the CDC’s opioid prescribing guideline is harming pain patients

By Kate M. Nicholson, Diane E. Hoffman, and Chad D. Kollas